These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15151778

  • 1. [Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure].
    Tamargo J, López-Sendón J.
    Rev Esp Cardiol; 2004 May; 57(5):447-64. PubMed ID: 15151778
    [Abstract] [Full Text] [Related]

  • 2. Rationale and design of the enoximone clinical trials program.
    Lowes BD, Shakar SF, Metra M, Feldman AM, Eichhorn E, Freytag JW, Gerber MJ, Liard JF, Hartman C, Gorczynski R, Evans G, Linseman JV, Stewart J, Robertson AD, Roecker EB, Demets DL, Bristow MR.
    J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
    [Abstract] [Full Text] [Related]

  • 3. Management of congestive heart failure: is the role of positive inotropic therapy fading?
    Futterman LG, Lemberg L.
    Am J Crit Care; 1996 Nov; 5(6):455-60. PubMed ID: 8922162
    [Abstract] [Full Text] [Related]

  • 4. Infusion therapy in severe heart failure. A reappraisal.
    Campana C, Scelsi L, Serio A.
    Ital Heart J; 2003 May; 4 Suppl 2():15S-21S. PubMed ID: 14635365
    [Abstract] [Full Text] [Related]

  • 5. Congestive heart failure: pathophysiology and management with special reference to systemic hypertension.
    Visser FC.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 4():S8-11. PubMed ID: 1721986
    [Abstract] [Full Text] [Related]

  • 6. What is evidence-based, what is new in medical therapy of acute heart failure?
    Grimm W.
    Herz; 2006 Nov; 31(8):771-9. PubMed ID: 17149679
    [Abstract] [Full Text] [Related]

  • 7. Evolving concepts in the treatment of heart failure: should new inotropic agents carry promise or paranoia?
    Young JB.
    Pharmacotherapy; 1996 Nov; 16(2 Pt 2):78S-84S. PubMed ID: 8668609
    [Abstract] [Full Text] [Related]

  • 8. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR, Krum H.
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [Abstract] [Full Text] [Related]

  • 9. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
    O'Connor CM, Arumugham P.
    Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
    [Abstract] [Full Text] [Related]

  • 10. [Controlled randomized clinical trials].
    Jaillon P.
    Bull Acad Natl Med; 2007 Feb; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [Abstract] [Full Text] [Related]

  • 11. Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
    Aronow WS.
    Clin Geriatr Med; 2007 Feb; 23(1):61-81. PubMed ID: 17126755
    [Abstract] [Full Text] [Related]

  • 12. Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?
    Fares WH.
    Heart Lung; 2008 Feb; 37(3):173-8. PubMed ID: 18482628
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of heart failure in the elderly].
    Zobel C, Schwinger RH.
    Med Klin (Munich); 2006 Mar 22; 101 Suppl 1():47-50. PubMed ID: 16802519
    [Abstract] [Full Text] [Related]

  • 14. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G, Sabbadini G, Zecchin M, Di Lenarda A.
    G Ital Cardiol (Rome); 2007 Sep 22; 8(9):559-67. PubMed ID: 17972425
    [Abstract] [Full Text] [Related]

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 22; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G, Di Lenarda A, Metra M, Nodari S, Moretti M, Brentana L, Dei Cas L, Sinagra G.
    Ital Heart J; 2004 Dec 22; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [Abstract] [Full Text] [Related]

  • 17. Overview of emerging pharmacotherapy in chronic heart failure.
    Szabó T, Felger D, von Haehling S, Lainscak M, Anker SD, Doehner W.
    Expert Opin Pharmacother; 2009 Sep 22; 10(13):2055-74. PubMed ID: 19606938
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Overview of randomized clinical trials in acute heart failure syndromes.
    Teerlink JR.
    Am J Cardiol; 2005 Sep 19; 96(6A):59G-67G. PubMed ID: 16181824
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 19; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.